Quarterly report pursuant to Section 13 or 15(d)

Debt (Tables)

v3.19.2
Debt (Tables)
6 Months Ended
Jun. 30, 2019
Debt Disclosure [Abstract]  
Schedule of Debt
At June 30, 2019 and December 31, 2018, we had notes payable and other debt (excluding the 2033 Senior Notes, the 2023 Convertible Notes, the 2025 Notes, the Credit Agreement and amounts outstanding under lines of credit described above) as follows:
(In thousands)
June 30,
2019
 
December 31,
2018
Current portion of notes payable
$
2,649

 
$
2,560

Other long-term liabilities
5,425

 
5,693

Total
$
8,074

 
$
8,253


The following table sets forth information related to the 2025 Notes which is included in our Condensed Consolidated Balance Sheet as of June 30, 2019:
(In thousands)
2025 Senior Notes
 
Discount
 
Debt Issuance Cost
 
Total
Balance at December 31, 2018
$

 
$

 
$

 
$

Issuance of 4.50% convertible notes
200,000

 
(52,600
)
 
(5,720
)
 
141,680

Amortization of debt discount and debt issuance costs

 
2,483

 
269

 
2,752

Balance at June 30, 2019
$
200,000

 
$
(50,117
)
 
$
(5,451
)
 
$
144,432


Summary of Lines of Credit
The following table summarizes the amounts outstanding under the BioReference, Chilean and Spanish lines of credit:
(Dollars in thousands)
 
 
 
 
 
 Balance Outstanding
Lender
 
Interest rate on
borrowings at June 30, 2019
 
Credit line
capacity
 
June 30,
2019
 
December 31,
2018
JPMorgan Chase
 
4.26%
 
$
100,000

 
$
68,559

 
$
105,198

Itau Bank
 
5.50%
 
1,810

 
1,287

 
232

Bank of Chile
 
6.60%
 
3,800

 
1,347

 
432

BICE Bank
 
5.50%
 
2,500

 
221

 
818

BBVA Bank
 
5.50%
 
3,250

 
472

 
858

Security Bank
 
5.50%
 
296

 
296

 

Estado Bank
 
5.50%
 
3,500

 
1,164

 
308

Santander Bank
 
5.50%
 
4,500

 
561

 
852

Scotiabank
 
5.00%
 
1,800

 
8

 
2

Banco De Sabadell
 
1.45%
 
341

 
126

 

Banco Bilbao Vizcaya
 
2.75%
 
341

 

 

Banco Santander
 
1.40%
 
341

 

 
10

Total
 
 
 
$
122,479

 
$
74,041

 
$
108,710